![]() |
Volumn 95, Issue 9, 2005, Pages 1359-1360
|
Evergreening: There's life in the old drug yet
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
DOXAZOSIN;
GENERIC DRUG;
OXYBUTYNIN;
TAMSULOSIN;
CARDIOVASCULAR DISEASE;
CONTROLLED RELEASE FORMULATION;
COST CONTROL;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG COST;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG SAFETY;
DRUG TOLERANCE;
ECONOMIC ASPECT;
EJACULATION DISORDER;
EVERGREENING;
HEALTH CARE COST;
HUMAN;
INVESTMENT;
ORTHOSTATIC HYPOTENSION;
PATENT;
PATIENT COMPLIANCE;
PERCEPTION;
PRIORITY JOURNAL;
PROFIT;
REVIEW;
STEADY STATE;
URGE INCONTINENCE;
ADMINISTRATION, ORAL;
ADRENERGIC ALPHA-ANTAGONISTS;
DELAYED-ACTION PREPARATIONS;
DRUG INDUSTRY;
HUMANS;
PATENTS;
SULFONAMIDES;
|
EID: 20444374498
PISSN: 14644096
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1464-410X.2005.05596.x Document Type: Review |
Times cited : (6)
|
References (2)
|